Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiangling Xiong

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Scientific Reports|August 26, 2021
Development of polyvinyl alcohol-based carbon nano fiber sheet for thermal interface materialJiangling Xiong, Siran Chen, Yongbum Choi, et al.
The International Journal of Biochemistry & Cell Biology|February 23, 2013
Integrin signaling in control of tumor growth and progressionJiangling Xiong, Hayri E Balcioglu, Erik H J Danen
Genomics, Proteomics & Bioinformatics|October 22, 2024
Comprehensive Characterization of the Integrin Family Across 32 Cancer TypesCheng Zou, Jinwei Zhu, Jiangling Xiong, et al.
Journal of Hematology & Oncology|October 30, 2021
Integrins regulate stemness in solid tumor: an emerging therapeutic targetJiangling Xiong, Lianlian Yan, Cheng Zou, et al.
Cellular and Molecular Life Sciences : CMLS|October 5, 2024
Stabilization of RRBP1 mRNA via an m<sup>6</sup>A-dependent manner in prostate cancer constitutes a therapeutic vulnerability amenable to small-peptide inhibition of METTL3Yuqing Feng, Zenghui Li, Jinwei Zhu, et al.
Biomaterials|October 25, 2011
Automated microinjection of cell-polymer suspensions in 3D ECM scaffolds for high-throughput quantitative cancer invasion screensHoa H Truong, Jan de Sonneville, Veerander P S Ghotra, et al.
Cancer Letters|September 1, 2024
Inhibition of PRMT5 moderately suppresses prostate cancer growth in vivo but enhances its response to immunotherapyQinju He, Yuanzhen Zhang, Wenchao Li, et al.
Science Signaling|February 13, 2014
β1 integrin inhibition elicits a prometastatic switch through the TGFβ-miR-200-ZEB network in E-cadherin-positive triple-negative breast cancerHoa H Truong, Jiangling Xiong, Veerander P S Ghotra, et al.
Cancer Research|November 13, 2014
SYK is a candidate kinase target for the treatment of advanced prostate cancerVeerander P S Ghotra, Shuning He, Geertje van der Horst, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Scientific Reports|August 26, 2021
Development of polyvinyl alcohol-based carbon nano fiber sheet for thermal interface materialJiangling Xiong, Siran Chen, Yongbum Choi, et al.
The International Journal of Biochemistry & Cell Biology|February 23, 2013
Integrin signaling in control of tumor growth and progressionJiangling Xiong, Hayri E Balcioglu, Erik H J Danen
Genomics, Proteomics & Bioinformatics|October 22, 2024
Comprehensive Characterization of the Integrin Family Across 32 Cancer TypesCheng Zou, Jinwei Zhu, Jiangling Xiong, et al.
Journal of Hematology & Oncology|October 30, 2021
Integrins regulate stemness in solid tumor: an emerging therapeutic targetJiangling Xiong, Lianlian Yan, Cheng Zou, et al.
Cellular and Molecular Life Sciences : CMLS|October 5, 2024
Stabilization of RRBP1 mRNA via an m<sup>6</sup>A-dependent manner in prostate cancer constitutes a therapeutic vulnerability amenable to small-peptide inhibition of METTL3Yuqing Feng, Zenghui Li, Jinwei Zhu, et al.
Biomaterials|October 25, 2011
Automated microinjection of cell-polymer suspensions in 3D ECM scaffolds for high-throughput quantitative cancer invasion screensHoa H Truong, Jan de Sonneville, Veerander P S Ghotra, et al.
Cancer Letters|September 1, 2024
Inhibition of PRMT5 moderately suppresses prostate cancer growth in vivo but enhances its response to immunotherapyQinju He, Yuanzhen Zhang, Wenchao Li, et al.
Science Signaling|February 13, 2014
β1 integrin inhibition elicits a prometastatic switch through the TGFβ-miR-200-ZEB network in E-cadherin-positive triple-negative breast cancerHoa H Truong, Jiangling Xiong, Veerander P S Ghotra, et al.
Cancer Research|November 13, 2014
SYK is a candidate kinase target for the treatment of advanced prostate cancerVeerander P S Ghotra, Shuning He, Geertje van der Horst, et al.
Pageof 1